Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph I. Clark, MD
Loyola University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Summit Medical Center
Oakland, California, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Norris Cotton Cancer Center
Lebanon, New Hampshire, United States
- Our Lady of Mercy Medical Center
The Bronx, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Earle A. Chiles Research Institute at Providence Portland Medical Center
Portland, Oregon, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 1997
- Primary completion
- 31 Aug 2002
- Completion
- 31 Aug 2002
- Last update posted
- 4 Jan 2017
- Registered enrollment
- 69
- Registry id
- NCT00003126
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.